OBJECTIVE: A common cause of dizziness, benign paroxysmal positional vertigo (BPPV), is effectively diagnosed and cured with the Dix-Hallpike test (DHT) and the canalith repositioning maneuver (CRM). We aimed to describe the use of these processes in emergency departments (EDs), assess for trends in use over time, and determine provider level variability in use. STUDY DESIGN: Prospective population-based surveillance study. SETTING: Emergency departments in Nueces County, Texas, from January 15, 2008, to January 14, 2011. SUBJECTS AND METHODS: Adult patients discharged from EDs with dizziness, vertigo, or imbalance documented at triage. Clinical information was abstracted from source documents. A hierarchical logistic regression model adjusting for patient and provider characteristics was used to estimate trends in DHT use and provider-level variability. RESULTS: A total of 3522 visits for dizziness were identified. A DHT was documented in 137 visits (3.9%). A CRM was documented in 8 visits (0.2%). Among patients diagnosed with BPPV, a DHT was documented in only 21.8% (34 of 156) and a CRM in 3.9% (6 of 156). In the hierarchical model (c-statistic = 0.93), DHT was less likely to be used over time (odds ratio, 0.97; 95% confidence interval, 0.95-0.99), and the provider level explained 50% (intraclass correlation coefficient, 0.50) of the variance in the probability of DHT use. CONCLUSION: Benign paroxysmal positional vertigo is seldom examined for and, when diagnosed, infrequently treated in this ED population. Use of the DHT is decreasing over time and varies substantially by provider. Implementation research focused on BPPV care may be an opportunity to optimize management in ED dizziness presentations.
OBJECTIVE: A common cause of dizziness, benign paroxysmal positional vertigo (BPPV), is effectively diagnosed and cured with the Dix-Hallpike test (DHT) and the canalith repositioning maneuver (CRM). We aimed to describe the use of these processes in emergency departments (EDs), assess for trends in use over time, and determine provider level variability in use. STUDY DESIGN: Prospective population-based surveillance study. SETTING: Emergency departments in Nueces County, Texas, from January 15, 2008, to January 14, 2011. SUBJECTS AND METHODS: Adult patients discharged from EDs with dizziness, vertigo, or imbalance documented at triage. Clinical information was abstracted from source documents. A hierarchical logistic regression model adjusting for patient and provider characteristics was used to estimate trends in DHT use and provider-level variability. RESULTS: A total of 3522 visits for dizziness were identified. A DHT was documented in 137 visits (3.9%). A CRM was documented in 8 visits (0.2%). Among patients diagnosed with BPPV, a DHT was documented in only 21.8% (34 of 156) and a CRM in 3.9% (6 of 156). In the hierarchical model (c-statistic = 0.93), DHT was less likely to be used over time (odds ratio, 0.97; 95% confidence interval, 0.95-0.99), and the provider level explained 50% (intraclass correlation coefficient, 0.50) of the variance in the probability of DHT use. CONCLUSION:Benign paroxysmal positional vertigo is seldom examined for and, when diagnosed, infrequently treated in this ED population. Use of the DHT is decreasing over time and varies substantially by provider. Implementation research focused on BPPV care may be an opportunity to optimize management in ED dizziness presentations.
Authors: Elliott S Fisher; David E Wennberg; Thérèse A Stukel; Daniel J Gottlieb; F L Lucas; Etoile L Pinder Journal: Ann Intern Med Date: 2003-02-18 Impact factor: 25.391
Authors: Elliott S Fisher; David E Wennberg; Thérèse A Stukel; Daniel J Gottlieb; F L Lucas; Etoile L Pinder Journal: Ann Intern Med Date: 2003-02-18 Impact factor: 25.391
Authors: M von Brevern; A Radtke; F Lezius; M Feldmann; T Ziese; T Lempert; H Neuhauser Journal: J Neurol Neurosurg Psychiatry Date: 2006-11-29 Impact factor: 10.154
Authors: Juan Merlo; Basile Chaix; Henrik Ohlsson; Anders Beckman; Kristina Johnell; Per Hjerpe; L Råstam; K Larsen Journal: J Epidemiol Community Health Date: 2006-04 Impact factor: 3.710
Authors: Michael F McDermott; Richard O Lenhardt; Catherine D Catrambone; James Walter; Kevin B Weiss Journal: Acad Emerg Med Date: 2006-02-22 Impact factor: 3.451
Authors: William J Meurer; Patricia Johnson; Devin Brown; Alexander Tsodikov; Brigid Rowell; Angela Fagerlin; Steven A Telian; Laura Damschroder; Lawrence C An; Lewis B Morgenstern; Kevin A Kerber Journal: Otol Neurotol Date: 2019-09 Impact factor: 2.311
Authors: Kevin A Kerber; Jane Forman; Laura Damschroder; Steven A Telian; Angela Fagerlin; Patricia Johnson; Devin L Brown; Lawrence C An; Lewis B Morgenstern; William J Meurer Journal: Neurol Clin Pract Date: 2017-06
Authors: Ali S Saber Tehrani; Jorge C Kattah; Kevin A Kerber; Daniel R Gold; David S Zee; Victor C Urrutia; David E Newman-Toker Journal: Stroke Date: 2018-02-19 Impact factor: 7.914
Authors: Kevin A Kerber; Laura Damschroder; Thomas McLaughlin; Devin L Brown; James F Burke; Steven A Telian; Alexander Tsodikov; Angela Fagerlin; Lawrence C An; Lewis B Morgenstern; Jane Forman; Sandeep Vijan; Brigid Rowell; William J Meurer Journal: Ann Emerg Med Date: 2019-12-20 Impact factor: 5.721